Axsome Therapeutics, Inc. - COM (AXSM)

Historical Portfolio Holders from Q4 2015 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
40.7M
Holdings value Q2 2024
$3.28B
Value change Q2 2024
+$196M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
250
Number of buys Q2 2024
107
Number of sells Q2 2024
-126
Average buys Q2 2024 %
+0.004%
Average sells Q2 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 27.9K $2.5M +$1.22M $89.85 3
2024 Q2 40.7M $3.28B +$196M $80.50 253
2024 Q1 38.3M $3.06B -$13.8M $79.80 252
2023 Q4 38.6M $3.07B +$53.4M $79.59 240
2023 Q3 37.6M $2.63B +$73.6M $69.89 225
2023 Q2 36.4M $2.61B +$329M $71.86 230
2023 Q1 31.9M $1.97B +$94.3M $61.68 199
2022 Q4 30M $2.32B +$384M $77.13 215
2022 Q3 25.7M $1.15B +$196M $44.62 183
2022 Q2 21.6M $826M +$91.4M $38.30 171
2022 Q1 19.1M $787M +$28.3M $41.39 168
2021 Q4 18.6M $703M -$19M $37.78 164
2021 Q3 19M $626M -$188M $32.96 167
2021 Q2 22.3M $1.51B -$37.8M $67.46 172
2021 Q1 22.9M $1.3B -$59.8M $56.62 183
2020 Q4 24M $1.95B -$4.13M $81.47 178
2020 Q3 24M $1.71B -$21.1M $71.25 171
2020 Q2 24.2M $1.99B +$152M $82.28 190
2020 Q1 22.8M $1.34B +$44.5M $58.83 166
2019 Q4 22.3M $2.3B +$376M $103.36 172
2019 Q3 18.8M $381M +$8.75M $20.24 112
2019 Q2 18.3M $470M +$100M $25.75 108
2019 Q1 14.7M $210M +$160M $14.23 64
2018 Q4 3.83M $10.8M +$479K $2.82 36
2018 Q3 3.53M $12.2M -$1.99M $3.45 33
2018 Q2 4.1M $13.1M -$297K $3.20 35
2018 Q1 4.23M $10.4M -$6.13M $2.45 35
2017 Q4 5.82M $32.6M -$1.05M $5.60 33
2017 Q3 6.01M $33.3M -$2.16M $5.55 28
2017 Q2 6.4M $35.3M -$6.15M $5.50 34
2017 Q1 7.75M $30.2M +$7.3M $3.90 47
2016 Q4 6.17M $41.6M -$967K $6.75 41
2016 Q3 6.31M $49.7M +$4.02M $7.88 36
2016 Q2 5.8M $43.7M +$3.93M $7.54 34
2016 Q1 5.26M $45.2M +$313K $8.60 17
2015 Q4 5.22M $47.7M +$47.7M $9.25 11